A Phase 3, Investigator-initiated, Randomized, Open-label Single-center Study of the Effect of Denosumab on the Prevention of Bone Mineral Density Loss After Renal Transplantation
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Acronyms POSTOP
- 01 Apr 2019 Results analysing the 1-year changes in trabecular bone score in 44 de novo Kidney transplant recipients published in the Nephrology Dialysis Transplantation.
- 28 Oct 2016 Results of post-hoc analysis published in the Transplantation.
- 07 Jan 2016 New trial record